Circadian Mechanisms, Glucose, and CV Risks in T1D — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Circadian Mechanisms, Glucose, and CV Risks in T1D — Stella

Home/Type 1 Diabetes (T1D)/

View on ClinicalTrials.gov

Recruiting

Back to Type 1 Diabetes (T1D) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Illinois Chicago, Chicago, Illinois

Key details

Sponsor

University of Illinois at Chicago

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~100 participants

Started

March 2025

Primary completion

February 2029

Age range

18 Years – 50 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.